Release of our first CSR Report!
We’re excited to announce the publication of our first CSR Report!
At HTL, we continuously explore groundbreaking applications for HA that extend far beyond today’s horizons.
We are continusly investing in innovation and improving the abilities of our premium Hyaluronic Acid to make it work better for future uses.
Caroline Robic, Innovation Director
“Due to their incredible properties, biopolymers are already key components for aesthetics, ophthalmology, and rheumatology areas.
At HTL, we really believe that they will soon play a key role in new indications like Oncology or vaccines.”